• Anglo French Drugs & Industries Ltd. Financial Results 2021

    8 July

Anglo-French Drugs has emerged as one of the admired pharmaceutical companies, not just in India but also worldwide. They are a brand leader in the B-complex market and are positioned amongst the top 3 manufacturers in India. AFDIL exports its products to the CIS, African, South East Asian countries.

They continue to support and improve millions of lives, with high quality drugs and a dedicated team of more than 750 employees supporting the medical fraternity to face the future challenges in healthcare.

Anglo French Drugs & Industries Ltd. Financial Results 2021

Total income of the company has been increased from INR 131.7 Cr. in 2020 to INR 154.8 Cr. in 2021, showcased a growth rate of 17.5%. Also, company's PAT has been increased at a growth rate of 141.5% from INR 3.1 Cr. in 2020 to INR 7.5 Cr. in 2021. Cash from operations has been decreased at a rate of 70.1%, from INR 15.1 Cr. in 2020 to INR 4.5 Cr. in 2021. Earnings per share has been increased at a growth rate of 131.8% from INR 26.7 in 2020 to INR 61.9 in 2021.